187 related articles for article (PubMed ID: 26930809)
1. [Application of embolic sclerotherapy for the treatment of painful venous malformation in limbs].
Yingying H; Tianxiang O; Yan X; Huiping C; Jie Y; Xiaorong M; Miao X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Sep; 31(5):352-5. PubMed ID: 26930809
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
[TBL] [Abstract][Full Text] [Related]
3. Peripheral venous malformations with a dominant outflow vein: results of ethanol embolization.
Rokni-Yazdi H; Ghajarzadeh M; Keyvan AH; Namavar MJ; Azizi S
Acta Med Iran; 2014; 52(11):868-71. PubMed ID: 25415823
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
5. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
[TBL] [Abstract][Full Text] [Related]
7. [Combined surgery and sclerotherapy for massive venous malformations of the tongue].
Huang X; Zou H; Guo X; Zhao Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jan; 32(1):14-7. PubMed ID: 27197473
[TBL] [Abstract][Full Text] [Related]
8. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular Venous Malformations of the Upper and Lower Limbs: Indications and Outcomes of Sclerotherapy.
Bianchini G; Camilli D; Furgiuele S
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1505-1512. PubMed ID: 29850938
[TBL] [Abstract][Full Text] [Related]
11. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
Songsaeng D; Churojana A; Khumthong R; Mahiwan L
J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
13. Ethanol sclerotherapy for venous malformation.
Steiner F; FitzJohn T; Tan ST
ANZ J Surg; 2016 Oct; 86(10):790-795. PubMed ID: 25182969
[TBL] [Abstract][Full Text] [Related]
14. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
[TBL] [Abstract][Full Text] [Related]
15. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
16. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
17. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
18. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
Kumar S; Bhavana K; Kumar S; Kumar P
J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
[TBL] [Abstract][Full Text] [Related]
20. Value of fat-suppressed T2-weighted imaging for predicting short-term pain relief after sclerotherapy for venous malformations in the extremities.
Nagata S; Tanaka N; Kuhara A; Kugiyama T; Tanoue S; Koganemaru M; Uchiyama Y; Fujimoto K; Abe T
Jpn J Radiol; 2023 Oct; 41(10):1157-1163. PubMed ID: 37170024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
